nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—NR1H4—bile—stomach cancer	0.0729	0.312	CbGeAlD
Fulvestrant—NR1H4—gall bladder—stomach cancer	0.0202	0.0867	CbGeAlD
Fulvestrant—NR1H4—hematopoietic system—stomach cancer	0.0115	0.0491	CbGeAlD
Fulvestrant—NR1H4—digestive system—stomach cancer	0.00797	0.0341	CbGeAlD
Fulvestrant—ESRRA—pancreas—stomach cancer	0.00714	0.0306	CbGeAlD
Fulvestrant—ESR1—blood vessel—stomach cancer	0.00677	0.029	CbGeAlD
Fulvestrant—NR1H4—endocrine gland—stomach cancer	0.00658	0.0282	CbGeAlD
Fulvestrant—ESRRA—digestive system—stomach cancer	0.0061	0.0261	CbGeAlD
Fulvestrant—NR1H4—liver—stomach cancer	0.00594	0.0254	CbGeAlD
Fulvestrant—ESRRA—bone marrow—stomach cancer	0.00562	0.0241	CbGeAlD
Fulvestrant—ESR2—hematopoietic system—stomach cancer	0.00526	0.0225	CbGeAlD
Fulvestrant—EPHX2—liver—stomach cancer	0.00519	0.0222	CbGeAlD
Fulvestrant—ESRRA—endocrine gland—stomach cancer	0.00504	0.0216	CbGeAlD
Fulvestrant—ESR2—epithelium—stomach cancer	0.00481	0.0206	CbGeAlD
Fulvestrant—ESR2—smooth muscle tissue—stomach cancer	0.00464	0.0199	CbGeAlD
Fulvestrant—NR1H4—lymph node—stomach cancer	0.00455	0.0195	CbGeAlD
Fulvestrant—ESRRA—liver—stomach cancer	0.00454	0.0195	CbGeAlD
Fulvestrant—EPHX2—lymph node—stomach cancer	0.00398	0.017	CbGeAlD
Fulvestrant—ESR2—lymphoid tissue—stomach cancer	0.00371	0.0159	CbGeAlD
Fulvestrant—ESR2—digestive system—stomach cancer	0.00366	0.0157	CbGeAlD
Fulvestrant—ESR1—hematopoietic system—stomach cancer	0.00361	0.0154	CbGeAlD
Fulvestrant—ESRRA—lymph node—stomach cancer	0.00348	0.0149	CbGeAlD
Fulvestrant—ESR1—epithelium—stomach cancer	0.0033	0.0141	CbGeAlD
Fulvestrant—ESR1—smooth muscle tissue—stomach cancer	0.00318	0.0136	CbGeAlD
Fulvestrant—ESR2—endocrine gland—stomach cancer	0.00303	0.013	CbGeAlD
Fulvestrant—ESR2—liver—stomach cancer	0.00273	0.0117	CbGeAlD
Fulvestrant—ESR1—lymphoid tissue—stomach cancer	0.00254	0.0109	CbGeAlD
Fulvestrant—ESR1—digestive system—stomach cancer	0.00251	0.0107	CbGeAlD
Fulvestrant—ESR2—lymph node—stomach cancer	0.00209	0.00895	CbGeAlD
Fulvestrant—ESR1—endocrine gland—stomach cancer	0.00207	0.00887	CbGeAlD
Fulvestrant—CYP3A4—hematopoietic system—stomach cancer	0.00201	0.00861	CbGeAlD
Fulvestrant—ESR1—liver—stomach cancer	0.00187	0.008	CbGeAlD
Fulvestrant—ESR1—lymph node—stomach cancer	0.00143	0.00613	CbGeAlD
Fulvestrant—CYP3A4—digestive system—stomach cancer	0.0014	0.00599	CbGeAlD
Fulvestrant—CYP3A4—endocrine gland—stomach cancer	0.00116	0.00495	CbGeAlD
Fulvestrant—CYP3A4—liver—stomach cancer	0.00104	0.00446	CbGeAlD
Fulvestrant—Abdominal pain—Irinotecan—stomach cancer	0.00062	0.00174	CcSEcCtD
Fulvestrant—Body temperature increased—Irinotecan—stomach cancer	0.00062	0.00174	CcSEcCtD
Fulvestrant—Anaemia—Docetaxel—stomach cancer	0.000614	0.00172	CcSEcCtD
Fulvestrant—Infestation NOS—Methotrexate—stomach cancer	0.000613	0.00172	CcSEcCtD
Fulvestrant—Infestation—Methotrexate—stomach cancer	0.000613	0.00172	CcSEcCtD
Fulvestrant—Depression—Methotrexate—stomach cancer	0.000611	0.00171	CcSEcCtD
Fulvestrant—Urticaria—Fluorouracil—stomach cancer	0.000597	0.00167	CcSEcCtD
Fulvestrant—Influenza—Doxorubicin—stomach cancer	0.000595	0.00167	CcSEcCtD
Fulvestrant—Leukopenia—Docetaxel—stomach cancer	0.000595	0.00167	CcSEcCtD
Fulvestrant—Anaemia—Capecitabine—stomach cancer	0.000595	0.00166	CcSEcCtD
Fulvestrant—Body temperature increased—Fluorouracil—stomach cancer	0.000594	0.00166	CcSEcCtD
Fulvestrant—Sweating—Methotrexate—stomach cancer	0.000588	0.00164	CcSEcCtD
Fulvestrant—Cough—Docetaxel—stomach cancer	0.00058	0.00162	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Methotrexate—stomach cancer	0.00058	0.00162	CcSEcCtD
Fulvestrant—Vertigo—Capecitabine—stomach cancer	0.000578	0.00162	CcSEcCtD
Fulvestrant—Hypersensitivity—Irinotecan—stomach cancer	0.000578	0.00162	CcSEcCtD
Fulvestrant—Leukopenia—Capecitabine—stomach cancer	0.000576	0.00161	CcSEcCtD
Fulvestrant—Infestation NOS—Epirubicin—stomach cancer	0.000574	0.00161	CcSEcCtD
Fulvestrant—Infestation—Epirubicin—stomach cancer	0.000574	0.00161	CcSEcCtD
Fulvestrant—Chest pain—Docetaxel—stomach cancer	0.000566	0.00158	CcSEcCtD
Fulvestrant—Myalgia—Docetaxel—stomach cancer	0.000566	0.00158	CcSEcCtD
Fulvestrant—Arthralgia—Docetaxel—stomach cancer	0.000566	0.00158	CcSEcCtD
Fulvestrant—Asthenia—Irinotecan—stomach cancer	0.000563	0.00158	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000562	0.00157	CcSEcCtD
Fulvestrant—Cough—Capecitabine—stomach cancer	0.000561	0.00157	CcSEcCtD
Fulvestrant—Urinary tract infection—Epirubicin—stomach cancer	0.000558	0.00156	CcSEcCtD
Fulvestrant—Hypersensitivity—Fluorouracil—stomach cancer	0.000554	0.00155	CcSEcCtD
Fulvestrant—Haemoglobin—Methotrexate—stomach cancer	0.000553	0.00155	CcSEcCtD
Fulvestrant—Haemorrhage—Methotrexate—stomach cancer	0.00055	0.00154	CcSEcCtD
Fulvestrant—Hepatitis—Methotrexate—stomach cancer	0.00055	0.00154	CcSEcCtD
Fulvestrant—Sweating—Epirubicin—stomach cancer	0.00055	0.00154	CcSEcCtD
Fulvestrant—Chest pain—Capecitabine—stomach cancer	0.000548	0.00153	CcSEcCtD
Fulvestrant—Myalgia—Capecitabine—stomach cancer	0.000548	0.00153	CcSEcCtD
Fulvestrant—Arthralgia—Capecitabine—stomach cancer	0.000548	0.00153	CcSEcCtD
Fulvestrant—Pharyngitis—Methotrexate—stomach cancer	0.000546	0.00153	CcSEcCtD
Fulvestrant—Anxiety—Capecitabine—stomach cancer	0.000546	0.00153	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000544	0.00152	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Epirubicin—stomach cancer	0.000542	0.00152	CcSEcCtD
Fulvestrant—Infection—Docetaxel—stomach cancer	0.000539	0.00151	CcSEcCtD
Fulvestrant—Diarrhoea—Irinotecan—stomach cancer	0.000537	0.0015	CcSEcCtD
Fulvestrant—Nervous system disorder—Docetaxel—stomach cancer	0.000532	0.00149	CcSEcCtD
Fulvestrant—Pruritus—Fluorouracil—stomach cancer	0.000532	0.00149	CcSEcCtD
Fulvestrant—Infestation NOS—Doxorubicin—stomach cancer	0.000531	0.00149	CcSEcCtD
Fulvestrant—Infestation—Doxorubicin—stomach cancer	0.000531	0.00149	CcSEcCtD
Fulvestrant—Skin disorder—Docetaxel—stomach cancer	0.000527	0.00147	CcSEcCtD
Fulvestrant—Infection—Capecitabine—stomach cancer	0.000522	0.00146	CcSEcCtD
Fulvestrant—Dizziness—Irinotecan—stomach cancer	0.000519	0.00145	CcSEcCtD
Fulvestrant—Haemoglobin—Epirubicin—stomach cancer	0.000518	0.00145	CcSEcCtD
Fulvestrant—Anorexia—Docetaxel—stomach cancer	0.000517	0.00145	CcSEcCtD
Fulvestrant—Urinary tract infection—Doxorubicin—stomach cancer	0.000516	0.00144	CcSEcCtD
Fulvestrant—Nervous system disorder—Capecitabine—stomach cancer	0.000515	0.00144	CcSEcCtD
Fulvestrant—Haemorrhage—Epirubicin—stomach cancer	0.000515	0.00144	CcSEcCtD
Fulvestrant—Hepatitis—Epirubicin—stomach cancer	0.000515	0.00144	CcSEcCtD
Fulvestrant—Diarrhoea—Fluorouracil—stomach cancer	0.000514	0.00144	CcSEcCtD
Fulvestrant—Pharyngitis—Epirubicin—stomach cancer	0.000511	0.00143	CcSEcCtD
Fulvestrant—Skin disorder—Capecitabine—stomach cancer	0.00051	0.00143	CcSEcCtD
Fulvestrant—Sweating—Doxorubicin—stomach cancer	0.000509	0.00142	CcSEcCtD
Fulvestrant—Hyperhidrosis—Capecitabine—stomach cancer	0.000508	0.00142	CcSEcCtD
Fulvestrant—Oedema peripheral—Epirubicin—stomach cancer	0.000507	0.00142	CcSEcCtD
Fulvestrant—Connective tissue disorder—Epirubicin—stomach cancer	0.000506	0.00142	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000502	0.00141	CcSEcCtD
Fulvestrant—Anorexia—Capecitabine—stomach cancer	0.000501	0.0014	CcSEcCtD
Fulvestrant—Angiopathy—Methotrexate—stomach cancer	0.000499	0.0014	CcSEcCtD
Fulvestrant—Vomiting—Irinotecan—stomach cancer	0.000499	0.0014	CcSEcCtD
Fulvestrant—Immune system disorder—Methotrexate—stomach cancer	0.000497	0.00139	CcSEcCtD
Fulvestrant—Dizziness—Fluorouracil—stomach cancer	0.000497	0.00139	CcSEcCtD
Fulvestrant—Rash—Irinotecan—stomach cancer	0.000495	0.00138	CcSEcCtD
Fulvestrant—Dermatitis—Irinotecan—stomach cancer	0.000494	0.00138	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000494	0.00138	CcSEcCtD
Fulvestrant—Headache—Irinotecan—stomach cancer	0.000492	0.00138	CcSEcCtD
Fulvestrant—Insomnia—Docetaxel—stomach cancer	0.000491	0.00137	CcSEcCtD
Fulvestrant—Paraesthesia—Docetaxel—stomach cancer	0.000487	0.00136	CcSEcCtD
Fulvestrant—Dyspnoea—Docetaxel—stomach cancer	0.000484	0.00135	CcSEcCtD
Fulvestrant—Malnutrition—Methotrexate—stomach cancer	0.000479	0.00134	CcSEcCtD
Fulvestrant—Haemoglobin—Doxorubicin—stomach cancer	0.000479	0.00134	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000478	0.00134	CcSEcCtD
Fulvestrant—Vomiting—Fluorouracil—stomach cancer	0.000478	0.00134	CcSEcCtD
Fulvestrant—Dyspepsia—Docetaxel—stomach cancer	0.000477	0.00134	CcSEcCtD
Fulvestrant—Haemorrhage—Doxorubicin—stomach cancer	0.000476	0.00133	CcSEcCtD
Fulvestrant—Hepatitis—Doxorubicin—stomach cancer	0.000476	0.00133	CcSEcCtD
Fulvestrant—Insomnia—Capecitabine—stomach cancer	0.000475	0.00133	CcSEcCtD
Fulvestrant—Rash—Fluorouracil—stomach cancer	0.000474	0.00133	CcSEcCtD
Fulvestrant—Dermatitis—Fluorouracil—stomach cancer	0.000473	0.00133	CcSEcCtD
Fulvestrant—Pharyngitis—Doxorubicin—stomach cancer	0.000473	0.00132	CcSEcCtD
Fulvestrant—Paraesthesia—Capecitabine—stomach cancer	0.000472	0.00132	CcSEcCtD
Fulvestrant—Decreased appetite—Docetaxel—stomach cancer	0.000471	0.00132	CcSEcCtD
Fulvestrant—Headache—Fluorouracil—stomach cancer	0.000471	0.00132	CcSEcCtD
Fulvestrant—Oedema peripheral—Doxorubicin—stomach cancer	0.000469	0.00131	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000468	0.00131	CcSEcCtD
Fulvestrant—Connective tissue disorder—Doxorubicin—stomach cancer	0.000468	0.00131	CcSEcCtD
Fulvestrant—Dyspnoea—Capecitabine—stomach cancer	0.000468	0.00131	CcSEcCtD
Fulvestrant—Fatigue—Docetaxel—stomach cancer	0.000468	0.00131	CcSEcCtD
Fulvestrant—Angiopathy—Epirubicin—stomach cancer	0.000467	0.00131	CcSEcCtD
Fulvestrant—Nausea—Irinotecan—stomach cancer	0.000466	0.0013	CcSEcCtD
Fulvestrant—Immune system disorder—Epirubicin—stomach cancer	0.000465	0.0013	CcSEcCtD
Fulvestrant—Pain—Docetaxel—stomach cancer	0.000464	0.0013	CcSEcCtD
Fulvestrant—Constipation—Docetaxel—stomach cancer	0.000464	0.0013	CcSEcCtD
Fulvestrant—Back pain—Methotrexate—stomach cancer	0.000463	0.0013	CcSEcCtD
Fulvestrant—Dyspepsia—Capecitabine—stomach cancer	0.000462	0.00129	CcSEcCtD
Fulvestrant—Decreased appetite—Capecitabine—stomach cancer	0.000456	0.00128	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000453	0.00127	CcSEcCtD
Fulvestrant—Fatigue—Capecitabine—stomach cancer	0.000453	0.00127	CcSEcCtD
Fulvestrant—Pain—Capecitabine—stomach cancer	0.000449	0.00126	CcSEcCtD
Fulvestrant—Constipation—Capecitabine—stomach cancer	0.000449	0.00126	CcSEcCtD
Fulvestrant—Malnutrition—Epirubicin—stomach cancer	0.000448	0.00125	CcSEcCtD
Fulvestrant—Nausea—Fluorouracil—stomach cancer	0.000446	0.00125	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Docetaxel—stomach cancer	0.000443	0.00124	CcSEcCtD
Fulvestrant—Anaemia—Methotrexate—stomach cancer	0.000443	0.00124	CcSEcCtD
Fulvestrant—Back pain—Epirubicin—stomach cancer	0.000434	0.00121	CcSEcCtD
Fulvestrant—Angiopathy—Doxorubicin—stomach cancer	0.000432	0.00121	CcSEcCtD
Fulvestrant—Immune system disorder—Doxorubicin—stomach cancer	0.00043	0.0012	CcSEcCtD
Fulvestrant—Vertigo—Methotrexate—stomach cancer	0.00043	0.0012	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Capecitabine—stomach cancer	0.000429	0.0012	CcSEcCtD
Fulvestrant—Body temperature increased—Docetaxel—stomach cancer	0.000429	0.0012	CcSEcCtD
Fulvestrant—Abdominal pain—Docetaxel—stomach cancer	0.000429	0.0012	CcSEcCtD
Fulvestrant—Leukopenia—Methotrexate—stomach cancer	0.000429	0.0012	CcSEcCtD
Fulvestrant—Cough—Methotrexate—stomach cancer	0.000418	0.00117	CcSEcCtD
Fulvestrant—Urticaria—Capecitabine—stomach cancer	0.000417	0.00117	CcSEcCtD
Fulvestrant—Body temperature increased—Capecitabine—stomach cancer	0.000415	0.00116	CcSEcCtD
Fulvestrant—Abdominal pain—Capecitabine—stomach cancer	0.000415	0.00116	CcSEcCtD
Fulvestrant—Malnutrition—Doxorubicin—stomach cancer	0.000415	0.00116	CcSEcCtD
Fulvestrant—Anaemia—Epirubicin—stomach cancer	0.000414	0.00116	CcSEcCtD
Fulvestrant—Myalgia—Methotrexate—stomach cancer	0.000408	0.00114	CcSEcCtD
Fulvestrant—Chest pain—Methotrexate—stomach cancer	0.000408	0.00114	CcSEcCtD
Fulvestrant—Arthralgia—Methotrexate—stomach cancer	0.000408	0.00114	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000405	0.00113	CcSEcCtD
Fulvestrant—Vertigo—Epirubicin—stomach cancer	0.000403	0.00113	CcSEcCtD
Fulvestrant—Leukopenia—Epirubicin—stomach cancer	0.000401	0.00112	CcSEcCtD
Fulvestrant—Back pain—Doxorubicin—stomach cancer	0.000401	0.00112	CcSEcCtD
Fulvestrant—Hypersensitivity—Docetaxel—stomach cancer	0.0004	0.00112	CcSEcCtD
Fulvestrant—Cough—Epirubicin—stomach cancer	0.000391	0.00109	CcSEcCtD
Fulvestrant—Asthenia—Docetaxel—stomach cancer	0.000389	0.00109	CcSEcCtD
Fulvestrant—Infection—Methotrexate—stomach cancer	0.000388	0.00109	CcSEcCtD
Fulvestrant—Hypersensitivity—Capecitabine—stomach cancer	0.000387	0.00108	CcSEcCtD
Fulvestrant—Pruritus—Docetaxel—stomach cancer	0.000384	0.00107	CcSEcCtD
Fulvestrant—Nervous system disorder—Methotrexate—stomach cancer	0.000383	0.00107	CcSEcCtD
Fulvestrant—Anaemia—Doxorubicin—stomach cancer	0.000383	0.00107	CcSEcCtD
Fulvestrant—Chest pain—Epirubicin—stomach cancer	0.000382	0.00107	CcSEcCtD
Fulvestrant—Myalgia—Epirubicin—stomach cancer	0.000382	0.00107	CcSEcCtD
Fulvestrant—Arthralgia—Epirubicin—stomach cancer	0.000382	0.00107	CcSEcCtD
Fulvestrant—Anxiety—Epirubicin—stomach cancer	0.00038	0.00106	CcSEcCtD
Fulvestrant—Skin disorder—Methotrexate—stomach cancer	0.00038	0.00106	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000379	0.00106	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methotrexate—stomach cancer	0.000378	0.00106	CcSEcCtD
Fulvestrant—Asthenia—Capecitabine—stomach cancer	0.000377	0.00105	CcSEcCtD
Fulvestrant—Vertigo—Doxorubicin—stomach cancer	0.000373	0.00104	CcSEcCtD
Fulvestrant—Anorexia—Methotrexate—stomach cancer	0.000373	0.00104	CcSEcCtD
Fulvestrant—Pruritus—Capecitabine—stomach cancer	0.000372	0.00104	CcSEcCtD
Fulvestrant—Leukopenia—Doxorubicin—stomach cancer	0.000371	0.00104	CcSEcCtD
Fulvestrant—Diarrhoea—Docetaxel—stomach cancer	0.000371	0.00104	CcSEcCtD
Fulvestrant—Infection—Epirubicin—stomach cancer	0.000363	0.00102	CcSEcCtD
Fulvestrant—Cough—Doxorubicin—stomach cancer	0.000362	0.00101	CcSEcCtD
Fulvestrant—Diarrhoea—Capecitabine—stomach cancer	0.000359	0.00101	CcSEcCtD
Fulvestrant—Nervous system disorder—Epirubicin—stomach cancer	0.000359	0.001	CcSEcCtD
Fulvestrant—Dizziness—Docetaxel—stomach cancer	0.000359	0.001	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000356	0.000997	CcSEcCtD
Fulvestrant—Skin disorder—Epirubicin—stomach cancer	0.000355	0.000995	CcSEcCtD
Fulvestrant—Hyperhidrosis—Epirubicin—stomach cancer	0.000354	0.00099	CcSEcCtD
Fulvestrant—Insomnia—Methotrexate—stomach cancer	0.000354	0.00099	CcSEcCtD
Fulvestrant—Myalgia—Doxorubicin—stomach cancer	0.000353	0.000988	CcSEcCtD
Fulvestrant—Chest pain—Doxorubicin—stomach cancer	0.000353	0.000988	CcSEcCtD
Fulvestrant—Arthralgia—Doxorubicin—stomach cancer	0.000353	0.000988	CcSEcCtD
Fulvestrant—Anxiety—Doxorubicin—stomach cancer	0.000352	0.000985	CcSEcCtD
Fulvestrant—Paraesthesia—Methotrexate—stomach cancer	0.000351	0.000983	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000351	0.000982	CcSEcCtD
Fulvestrant—Anorexia—Epirubicin—stomach cancer	0.000349	0.000976	CcSEcCtD
Fulvestrant—Dyspnoea—Methotrexate—stomach cancer	0.000349	0.000976	CcSEcCtD
Fulvestrant—Dizziness—Capecitabine—stomach cancer	0.000347	0.000972	CcSEcCtD
Fulvestrant—Vomiting—Docetaxel—stomach cancer	0.000345	0.000965	CcSEcCtD
Fulvestrant—Dyspepsia—Methotrexate—stomach cancer	0.000344	0.000963	CcSEcCtD
Fulvestrant—Rash—Docetaxel—stomach cancer	0.000342	0.000957	CcSEcCtD
Fulvestrant—Dermatitis—Docetaxel—stomach cancer	0.000342	0.000956	CcSEcCtD
Fulvestrant—Decreased appetite—Methotrexate—stomach cancer	0.00034	0.000951	CcSEcCtD
Fulvestrant—Headache—Docetaxel—stomach cancer	0.00034	0.000951	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000337	0.000945	CcSEcCtD
Fulvestrant—Fatigue—Methotrexate—stomach cancer	0.000337	0.000943	CcSEcCtD
Fulvestrant—Infection—Doxorubicin—stomach cancer	0.000336	0.000941	CcSEcCtD
Fulvestrant—Pain—Methotrexate—stomach cancer	0.000334	0.000936	CcSEcCtD
Fulvestrant—Vomiting—Capecitabine—stomach cancer	0.000334	0.000935	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000333	0.000933	CcSEcCtD
Fulvestrant—Nervous system disorder—Doxorubicin—stomach cancer	0.000332	0.000929	CcSEcCtD
Fulvestrant—Rash—Capecitabine—stomach cancer	0.000331	0.000927	CcSEcCtD
Fulvestrant—Insomnia—Epirubicin—stomach cancer	0.000331	0.000926	CcSEcCtD
Fulvestrant—Dermatitis—Capecitabine—stomach cancer	0.000331	0.000926	CcSEcCtD
Fulvestrant—Headache—Capecitabine—stomach cancer	0.000329	0.000921	CcSEcCtD
Fulvestrant—Skin disorder—Doxorubicin—stomach cancer	0.000329	0.00092	CcSEcCtD
Fulvestrant—Paraesthesia—Epirubicin—stomach cancer	0.000328	0.00092	CcSEcCtD
Fulvestrant—Hyperhidrosis—Doxorubicin—stomach cancer	0.000327	0.000916	CcSEcCtD
Fulvestrant—Dyspnoea—Epirubicin—stomach cancer	0.000326	0.000913	CcSEcCtD
Fulvestrant—Anorexia—Doxorubicin—stomach cancer	0.000323	0.000903	CcSEcCtD
Fulvestrant—Nausea—Docetaxel—stomach cancer	0.000322	0.000902	CcSEcCtD
Fulvestrant—Dyspepsia—Epirubicin—stomach cancer	0.000322	0.000901	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methotrexate—stomach cancer	0.00032	0.000895	CcSEcCtD
Fulvestrant—Decreased appetite—Epirubicin—stomach cancer	0.000318	0.00089	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000316	0.000884	CcSEcCtD
Fulvestrant—Fatigue—Epirubicin—stomach cancer	0.000315	0.000883	CcSEcCtD
Fulvestrant—Pain—Epirubicin—stomach cancer	0.000313	0.000876	CcSEcCtD
Fulvestrant—Constipation—Epirubicin—stomach cancer	0.000313	0.000876	CcSEcCtD
Fulvestrant—Nausea—Capecitabine—stomach cancer	0.000312	0.000873	CcSEcCtD
Fulvestrant—Urticaria—Methotrexate—stomach cancer	0.000311	0.000869	CcSEcCtD
Fulvestrant—Abdominal pain—Methotrexate—stomach cancer	0.000309	0.000865	CcSEcCtD
Fulvestrant—Body temperature increased—Methotrexate—stomach cancer	0.000309	0.000865	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000308	0.000863	CcSEcCtD
Fulvestrant—Insomnia—Doxorubicin—stomach cancer	0.000306	0.000857	CcSEcCtD
Fulvestrant—Paraesthesia—Doxorubicin—stomach cancer	0.000304	0.000851	CcSEcCtD
Fulvestrant—Dyspnoea—Doxorubicin—stomach cancer	0.000302	0.000845	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Epirubicin—stomach cancer	0.000299	0.000837	CcSEcCtD
Fulvestrant—Dyspepsia—Doxorubicin—stomach cancer	0.000298	0.000834	CcSEcCtD
Fulvestrant—Decreased appetite—Doxorubicin—stomach cancer	0.000294	0.000824	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000292	0.000818	CcSEcCtD
Fulvestrant—Fatigue—Doxorubicin—stomach cancer	0.000292	0.000817	CcSEcCtD
Fulvestrant—Urticaria—Epirubicin—stomach cancer	0.000291	0.000814	CcSEcCtD
Fulvestrant—Constipation—Doxorubicin—stomach cancer	0.000289	0.00081	CcSEcCtD
Fulvestrant—Pain—Doxorubicin—stomach cancer	0.000289	0.00081	CcSEcCtD
Fulvestrant—Body temperature increased—Epirubicin—stomach cancer	0.000289	0.00081	CcSEcCtD
Fulvestrant—Abdominal pain—Epirubicin—stomach cancer	0.000289	0.00081	CcSEcCtD
Fulvestrant—Hypersensitivity—Methotrexate—stomach cancer	0.000288	0.000806	CcSEcCtD
Fulvestrant—Asthenia—Methotrexate—stomach cancer	0.00028	0.000785	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000277	0.000775	CcSEcCtD
Fulvestrant—Pruritus—Methotrexate—stomach cancer	0.000277	0.000774	CcSEcCtD
Fulvestrant—Hypersensitivity—Epirubicin—stomach cancer	0.00027	0.000755	CcSEcCtD
Fulvestrant—Urticaria—Doxorubicin—stomach cancer	0.000269	0.000753	CcSEcCtD
Fulvestrant—Body temperature increased—Doxorubicin—stomach cancer	0.000268	0.000749	CcSEcCtD
Fulvestrant—Abdominal pain—Doxorubicin—stomach cancer	0.000268	0.000749	CcSEcCtD
Fulvestrant—Diarrhoea—Methotrexate—stomach cancer	0.000267	0.000749	CcSEcCtD
Fulvestrant—Asthenia—Epirubicin—stomach cancer	0.000262	0.000735	CcSEcCtD
Fulvestrant—Pruritus—Epirubicin—stomach cancer	0.000259	0.000725	CcSEcCtD
Fulvestrant—Dizziness—Methotrexate—stomach cancer	0.000258	0.000724	CcSEcCtD
Fulvestrant—Diarrhoea—Epirubicin—stomach cancer	0.00025	0.000701	CcSEcCtD
Fulvestrant—Hypersensitivity—Doxorubicin—stomach cancer	0.000249	0.000698	CcSEcCtD
Fulvestrant—Vomiting—Methotrexate—stomach cancer	0.000249	0.000696	CcSEcCtD
Fulvestrant—Rash—Methotrexate—stomach cancer	0.000246	0.00069	CcSEcCtD
Fulvestrant—Dermatitis—Methotrexate—stomach cancer	0.000246	0.000689	CcSEcCtD
Fulvestrant—Headache—Methotrexate—stomach cancer	0.000245	0.000686	CcSEcCtD
Fulvestrant—Asthenia—Doxorubicin—stomach cancer	0.000243	0.00068	CcSEcCtD
Fulvestrant—Dizziness—Epirubicin—stomach cancer	0.000242	0.000677	CcSEcCtD
Fulvestrant—Pruritus—Doxorubicin—stomach cancer	0.000239	0.00067	CcSEcCtD
Fulvestrant—Vomiting—Epirubicin—stomach cancer	0.000233	0.000651	CcSEcCtD
Fulvestrant—Nausea—Methotrexate—stomach cancer	0.000232	0.00065	CcSEcCtD
Fulvestrant—Diarrhoea—Doxorubicin—stomach cancer	0.000232	0.000648	CcSEcCtD
Fulvestrant—Rash—Epirubicin—stomach cancer	0.000231	0.000646	CcSEcCtD
Fulvestrant—Dermatitis—Epirubicin—stomach cancer	0.00023	0.000645	CcSEcCtD
Fulvestrant—Headache—Epirubicin—stomach cancer	0.000229	0.000642	CcSEcCtD
Fulvestrant—Dizziness—Doxorubicin—stomach cancer	0.000224	0.000627	CcSEcCtD
Fulvestrant—Nausea—Epirubicin—stomach cancer	0.000217	0.000608	CcSEcCtD
Fulvestrant—Vomiting—Doxorubicin—stomach cancer	0.000215	0.000602	CcSEcCtD
Fulvestrant—Rash—Doxorubicin—stomach cancer	0.000213	0.000597	CcSEcCtD
Fulvestrant—Dermatitis—Doxorubicin—stomach cancer	0.000213	0.000597	CcSEcCtD
Fulvestrant—Headache—Doxorubicin—stomach cancer	0.000212	0.000594	CcSEcCtD
Fulvestrant—Nausea—Doxorubicin—stomach cancer	0.000201	0.000563	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—DNMT1—stomach cancer	0.000127	0.000311	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ERCC2—stomach cancer	0.000127	0.00031	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000127	0.00031	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—HRAS—stomach cancer	0.000126	0.000309	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA8—stomach cancer	0.000126	0.000307	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	0.000124	0.000303	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTT1—stomach cancer	0.000124	0.000303	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP2A6—stomach cancer	0.000122	0.000299	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPP2R1A—stomach cancer	0.00012	0.000293	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1B—stomach cancer	0.000119	0.000292	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTHFR—stomach cancer	0.000119	0.000292	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKR1C3—stomach cancer	0.000119	0.000291	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SERPINE1—stomach cancer	0.000118	0.000289	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPS6—stomach cancer	0.000118	0.000288	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—MYC—stomach cancer	0.000118	0.000288	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTP1—stomach cancer	0.000117	0.000287	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ENO1—stomach cancer	0.000116	0.000284	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—stomach cancer	0.000116	0.000283	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CCND1—stomach cancer	0.000114	0.00028	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—JUN—stomach cancer	0.000114	0.000279	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000114	0.000279	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RXRB—stomach cancer	0.000114	0.000279	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPP2R1A—stomach cancer	0.000113	0.000275	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL18—stomach cancer	0.000112	0.000273	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL13—stomach cancer	0.000112	0.000273	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1A—stomach cancer	0.00011	0.000269	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CAV1—stomach cancer	0.00011	0.000269	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—APOA1—stomach cancer	0.00011	0.000268	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—TYMS—stomach cancer	0.000109	0.000267	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—stomach cancer	0.000109	0.000265	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—stomach cancer	0.000108	0.000264	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	0.000107	0.000262	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GLI3—stomach cancer	0.000107	0.000262	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KISS1R—stomach cancer	0.000107	0.000262	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	0.000105	0.000257	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	0.000105	0.000257	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SMAD4—stomach cancer	0.000104	0.000255	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS21—stomach cancer	0.000104	0.000255	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS15—stomach cancer	0.000104	0.000255	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000104	0.000253	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CD44—stomach cancer	0.000103	0.000251	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SNRPB—stomach cancer	0.000103	0.000251	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000102	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBP1—stomach cancer	0.000102	0.000249	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ERCC2—stomach cancer	0.000101	0.000248	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.98e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—stomach cancer	9.98e-05	0.000244	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—stomach cancer	9.95e-05	0.000243	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	9.94e-05	0.000243	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	9.83e-05	0.00024	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPP2R1A—stomach cancer	9.8e-05	0.000239	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—stomach cancer	9.68e-05	0.000236	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTHFR—stomach cancer	9.54e-05	0.000233	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ERCC2—stomach cancer	9.54e-05	0.000233	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SMAD4—stomach cancer	9.53e-05	0.000233	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	9.49e-05	0.000232	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	9.47e-05	0.000231	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK3—stomach cancer	9.39e-05	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RORA—stomach cancer	9.23e-05	0.000225	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MYC—stomach cancer	9.18e-05	0.000224	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	9.18e-05	0.000224	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SMAD4—stomach cancer	9.1e-05	0.000222	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MAPK1—stomach cancer	8.98e-05	0.00022	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—stomach cancer	8.98e-05	0.00022	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—stomach cancer	8.96e-05	0.000219	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	8.96e-05	0.000219	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—MAPK1—stomach cancer	8.94e-05	0.000218	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—stomach cancer	8.93e-05	0.000218	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CAV1—stomach cancer	8.8e-05	0.000215	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APOA1—stomach cancer	8.78e-05	0.000215	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPP2R1A—stomach cancer	8.75e-05	0.000214	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—stomach cancer	8.7e-05	0.000213	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT3B—stomach cancer	8.65e-05	0.000211	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—MYC—stomach cancer	8.61e-05	0.00021	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—stomach cancer	8.58e-05	0.00021	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—KRAS—stomach cancer	8.49e-05	0.000207	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL15—stomach cancer	8.48e-05	0.000207	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—stomach cancer	8.46e-05	0.000207	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—KRAS—stomach cancer	8.44e-05	0.000206	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.41e-05	0.000205	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—WWOX—stomach cancer	8.32e-05	0.000203	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—stomach cancer	8.32e-05	0.000203	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—ERCC2—stomach cancer	8.31e-05	0.000203	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	8.27e-05	0.000202	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RARB—stomach cancer	8.25e-05	0.000202	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TYMS—stomach cancer	7.98e-05	0.000195	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS26—stomach cancer	7.91e-05	0.000193	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—stomach cancer	7.89e-05	0.000193	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	7.82e-05	0.000191	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—PIK3CA—stomach cancer	7.75e-05	0.00019	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRH4—stomach cancer	7.74e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—WIF1—stomach cancer	7.74e-05	0.000189	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—stomach cancer	7.73e-05	0.000189	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—stomach cancer	7.61e-05	0.000186	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	7.61e-05	0.000186	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—stomach cancer	7.54e-05	0.000184	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—MYC—stomach cancer	7.5e-05	0.000183	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	7.44e-05	0.000182	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	7.44e-05	0.000182	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ERCC2—stomach cancer	7.42e-05	0.000181	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—stomach cancer	7.27e-05	0.000178	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—stomach cancer	7.18e-05	0.000176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—HRAS—stomach cancer	7.17e-05	0.000175	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKAB1—stomach cancer	7.14e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	7.09e-05	0.000173	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	7.09e-05	0.000173	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	7.03e-05	0.000172	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—stomach cancer	6.97e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—stomach cancer	6.95e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPB1—stomach cancer	6.91e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KISS1—stomach cancer	6.9e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RNF43—stomach cancer	6.9e-05	0.000169	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—stomach cancer	6.87e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS19—stomach cancer	6.72e-05	0.000164	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—stomach cancer	6.65e-05	0.000163	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—stomach cancer	6.63e-05	0.000162	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6.6e-05	0.000161	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—stomach cancer	6.55e-05	0.00016	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	6.51e-05	0.000159	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.46e-05	0.000158	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CAV1—stomach cancer	6.43e-05	0.000157	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT1—stomach cancer	6.43e-05	0.000157	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—stomach cancer	6.42e-05	0.000157	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA8—stomach cancer	6.34e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—stomach cancer	6.33e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	6.25e-05	0.000153	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ACAD8—stomach cancer	6.18e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FST—stomach cancer	6.15e-05	0.00015	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.14e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—stomach cancer	6.08e-05	0.000149	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—stomach cancer	5.97e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPS6—stomach cancer	5.95e-05	0.000145	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAST—stomach cancer	5.93e-05	0.000145	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RGS2—stomach cancer	5.93e-05	0.000145	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MAPK3—stomach cancer	5.83e-05	0.000142	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—stomach cancer	5.7e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MYC—stomach cancer	5.67e-05	0.000139	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—stomach cancer	5.65e-05	0.000138	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGG—stomach cancer	5.62e-05	0.000137	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GMPR2—stomach cancer	5.5e-05	0.000135	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKAA1—stomach cancer	5.41e-05	0.000132	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBP4—stomach cancer	5.23e-05	0.000128	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—stomach cancer	5.08e-05	0.000124	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—IDH3B—stomach cancer	5.03e-05	0.000123	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SUCLG1—stomach cancer	5.03e-05	0.000123	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPP2R1A—stomach cancer	4.94e-05	0.000121	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—stomach cancer	4.86e-05	0.000119	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—stomach cancer	4.68e-05	0.000114	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.68e-05	0.000114	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.68e-05	0.000114	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SMAD4—stomach cancer	4.59e-05	0.000112	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR2—stomach cancer	4.49e-05	0.00011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HSPB1—stomach cancer	4.49e-05	0.00011	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—stomach cancer	4.45e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BMP2—stomach cancer	4.44e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2R—stomach cancer	4.44e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKR1C3—stomach cancer	4.37e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR1A—stomach cancer	4.33e-05	0.000106	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MAPK3—stomach cancer	4.26e-05	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ERCC2—stomach cancer	4.19e-05	0.000102	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ANXA1—stomach cancer	4.18e-05	0.000102	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—BLVRB—stomach cancer	4.17e-05	0.000102	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PGLS—stomach cancer	4.17e-05	0.000102	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MYC—stomach cancer	4.14e-05	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB1—stomach cancer	4.05e-05	9.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.98e-05	9.73e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RPS6—stomach cancer	3.87e-05	9.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—MYC—stomach cancer	3.78e-05	9.24e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—stomach cancer	3.74e-05	9.15e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MAPK3—stomach cancer	3.71e-05	9.07e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—MYC—stomach cancer	3.61e-05	8.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HBEGF—stomach cancer	3.55e-05	8.68e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA1—stomach cancer	3.55e-05	8.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKB—stomach cancer	3.55e-05	8.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.55e-05	8.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FBP1—stomach cancer	3.55e-05	8.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLIN2—stomach cancer	3.34e-05	8.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—stomach cancer	3.28e-05	8.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CA2—stomach cancer	3.24e-05	7.93e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2R1A—stomach cancer	3.21e-05	7.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—stomach cancer	3.19e-05	7.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NT5E—stomach cancer	3.16e-05	7.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PGAM1—stomach cancer	3.16e-05	7.73e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCE1—stomach cancer	3.02e-05	7.37e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.02e-05	7.37e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMAD4—stomach cancer	2.98e-05	7.29e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UMPS—stomach cancer	2.89e-05	7.07e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—stomach cancer	2.88e-05	7.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FYN—stomach cancer	2.83e-05	6.92e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—stomach cancer	2.74e-05	6.69e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ECHS1—stomach cancer	2.69e-05	6.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PDHA1—stomach cancer	2.69e-05	6.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGFR2—stomach cancer	2.66e-05	6.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FADS1—stomach cancer	2.53e-05	6.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TYMP—stomach cancer	2.53e-05	6.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS2—stomach cancer	2.43e-05	5.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SREBF2—stomach cancer	2.37e-05	5.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CAV1—stomach cancer	2.36e-05	5.77e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—stomach cancer	2.36e-05	5.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RORA—stomach cancer	2.34e-05	5.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCB—stomach cancer	2.25e-05	5.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6ST—stomach cancer	2.24e-05	5.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDOB—stomach cancer	2.19e-05	5.36e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APC—stomach cancer	2.15e-05	5.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALOX5—stomach cancer	2.04e-05	4.98e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DPYD—stomach cancer	2e-05	4.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6R—stomach cancer	2e-05	4.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MAPK3—stomach cancer	1.87e-05	4.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—stomach cancer	1.87e-05	4.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MYC—stomach cancer	1.82e-05	4.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RHOA—stomach cancer	1.8e-05	4.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—stomach cancer	1.79e-05	4.36e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—stomach cancer	1.77e-05	4.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.75e-05	4.28e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.7e-05	4.17e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB2—stomach cancer	1.67e-05	4.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ENO1—stomach cancer	1.66e-05	4.06e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—stomach cancer	1.58e-05	3.87e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1B—stomach cancer	1.55e-05	3.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—stomach cancer	1.48e-05	3.61e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD44—stomach cancer	1.47e-05	3.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUN—stomach cancer	1.47e-05	3.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—stomach cancer	1.43e-05	3.5e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1A—stomach cancer	1.43e-05	3.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—stomach cancer	1.39e-05	3.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—stomach cancer	1.29e-05	3.14e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—stomach cancer	1.27e-05	3.11e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.25e-05	3.06e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—stomach cancer	1.23e-05	3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK3—stomach cancer	1.22e-05	2.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—stomach cancer	1.21e-05	2.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MYC—stomach cancer	1.18e-05	2.89e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK1—stomach cancer	1.16e-05	2.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—stomach cancer	1.16e-05	2.83e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TYMS—stomach cancer	1.14e-05	2.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—stomach cancer	1.13e-05	2.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KRAS—stomach cancer	1.09e-05	2.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ERCC2—stomach cancer	1.06e-05	2.59e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—stomach cancer	1e-05	2.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—stomach cancer	9.98e-06	2.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—stomach cancer	9.72e-06	2.37e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HRAS—stomach cancer	9.29e-06	2.27e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAV1—stomach cancer	9.2e-06	2.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—stomach cancer	9.18e-06	2.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—stomach cancer	8.89e-06	2.17e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—stomach cancer	8.09e-06	1.98e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—stomach cancer	7.28e-06	1.78e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—stomach cancer	6.96e-06	1.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—stomach cancer	6.36e-06	1.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.92e-06	9.57e-06	CbGpPWpGaD
